{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-087486","form_type":"8-K","ticker":"TRVI","cik":"0001563880","company_name":"Trevi Therapeutics, Inc.","filed_at":"2025-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.784365+00:00","generated_at":"2026-05-19T04:35:10.605596+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Trevi shareholders approve 6M share increase for 2019 Stock Incentive Plan","bullets":["Stockholders voted to increase authorized shares under the 2019 Plan by 6,000,000 shares.","Class III directors Jennifer Good and Anne VanLent re-elected with 78.8M and 62.9M votes for, respectively.","Ratification of Ernst & Young as auditor for FY2025 passed with 88.9M votes for.","Advisory say-on-pay approved (78.3M for, 0.7M against); future votes will be held every year.","All proposals, including the equity plan amendment, received required majority approval."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-087486","json":"https://secwatch.observer/filing/0000950170-25-087486.json","markdown":"https://secwatch.observer/filing/0000950170-25-087486.md","text":"https://secwatch.observer/filing/0000950170-25-087486.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563880/000095017025087486/0000950170-25-087486-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563880/000095017025087486/trvi-20250611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T04:35:10.605596+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}